These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

576 related items for PubMed ID: 31128197

  • 1. Enhancement of oral bioavailability of poorly water soluble carvedilol by chitosan nanoparticles: Optimization and pharmacokinetic study.
    Sharma M, Sharma R, Jain DK, Saraf A.
    Int J Biol Macromol; 2019 Aug 15; 135():246-260. PubMed ID: 31128197
    [Abstract] [Full Text] [Related]

  • 2. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
    Li T, Geng T, Md A, Banerjee P, Wang B.
    Colloids Surf B Biointerfaces; 2019 Apr 01; 176():185-193. PubMed ID: 30616109
    [Abstract] [Full Text] [Related]

  • 3. Application of Statistical Tooling Techniques for Designing of Carvedilol Nanolipid Transferosomes and its Dermatopharmacokinetic and Pharmacodynamic Studies.
    Selvaraj BR, Sridhar SK, Kesavan BR, Palagati S.
    Pharm Nanotechnol; 2020 Apr 01; 8(6):452-470. PubMed ID: 32988361
    [Abstract] [Full Text] [Related]

  • 4. Labrasol-Enriched Nanoliposomal Formulation: Novel Approach to Improve Oral Absorption of Water-Insoluble Drug, Carvedilol.
    Ghassemi S, Haeri A, Shahhosseini S, Dadashzadeh S.
    AAPS PharmSciTech; 2018 Oct 01; 19(7):2961-2970. PubMed ID: 30030724
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
    Rukmangathen R, Yallamalli IM, Yalavarthi PR.
    Drug Dev Ind Pharm; 2019 Aug 01; 45(8):1342-1350. PubMed ID: 31094571
    [Abstract] [Full Text] [Related]

  • 12. Chitosan-TPP nanoparticles stabilized by poloxamer for controlling the release and enhancing the bioavailability of doxazosin mesylate: in vitro, and in vivo evaluation.
    Aljaeid BM, El-Say KM, Hosny KM.
    Drug Dev Ind Pharm; 2019 Jul 01; 45(7):1130-1139. PubMed ID: 30884977
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Thymoquinone-entrapped chitosan-modified nanoparticles: formulation optimization to preclinical bioavailability assessments.
    Rahat I, Imam SS, Rizwanullah M, Alshehri S, Asif M, Kala C, Taleuzzaman M.
    Drug Deliv; 2021 Dec 01; 28(1):973-984. PubMed ID: 34036860
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Formulation, optimization and characterization of cationic polymeric nanoparticles of mast cell stabilizing agent using the Box-Behnken experimental design.
    Gajra B, Patel RR, Dalwadi C.
    Drug Dev Ind Pharm; 2016 Dec 01; 42(5):747-57. PubMed ID: 26559522
    [Abstract] [Full Text] [Related]

  • 17. Bio-fabrication and statistical optimization of polysorbate 80 coated chitosan nanoparticles of tapentadol hydrochloride for central antinociceptive effect: in vitro-in vivo studies.
    Patil GB, Surana SJ.
    Artif Cells Nanomed Biotechnol; 2017 May 01; 45(3):505-514. PubMed ID: 27017892
    [Abstract] [Full Text] [Related]

  • 18. Daunorubicin oral bioavailability enhancement by surface coated natural biodegradable macromolecule chitosan based polymeric nanoparticles.
    Ahmad N, Ahmad R, Alam MA, Ahmad FJ, Amir M, Pottoo FH, Sarafroz M, Jafar M, Umar K.
    Int J Biol Macromol; 2019 May 01; 128():825-838. PubMed ID: 30690115
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.